Antipneumococcal activity of BMS 284756 compared to those of six other agents.
about
Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY program, 1999 to 2001.In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmasInvestigational new drugs for the treatment of resistant pneumococcal infections.Postantibiotic effects of garenoxacin (BMS-284756) against 12 gram-positive or -negative organisms.In vitro activities of garenoxacin (BMS-284756) against Streptococcus pneumoniae, viridans group streptococci, and Enterococcus faecalis compared to those of six other quinolones.In vitro activities of garenoxacin (BMS-284756) against Haemophilus influenzae isolates with different fluoroquinolone susceptibilities.
P2860
Antipneumococcal activity of BMS 284756 compared to those of six other agents.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Antipneumococcal activity of BMS 284756 compared to those of six other agents.
@en
Antipneumococcal activity of BMS 284756 compared to those of six other agents.
@nl
type
label
Antipneumococcal activity of BMS 284756 compared to those of six other agents.
@en
Antipneumococcal activity of BMS 284756 compared to those of six other agents.
@nl
prefLabel
Antipneumococcal activity of BMS 284756 compared to those of six other agents.
@en
Antipneumococcal activity of BMS 284756 compared to those of six other agents.
@nl
P2093
P2860
P1476
Antipneumococcal activity of BMS 284756 compared to those of six other agents.
@en
P2093
Glenn A Pankuch
Kensuke Nagai
Michael R Jacobs
Peter C Appelbaum
Todd A Davies
P2860
P304
P356
10.1128/AAC.46.1.251-254.2002
P407
P577
2002-01-01T00:00:00Z